Received Jul 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | UNK | — | OT / RA |
Just some sleepiness; Had very little side effects in the aftermath of my first dose; She had her first dose, but needs to find a place to get her second dose...Hasn't had any previous COVID-19 vaccines before her Novavax vaccine; This non-serious initial spontaneous report was reported by a consumer or other non-health professional via contact center (MI No. NOV25-00196) and concerns a 23-year-old Female who experienced "JUST SOME SLEEPINESS" on an unknown date and "SHE HAD HER FIRST DOSE, BUT NEEDS TO FIND A PLACE TO GET HER SECOND DOSE...HASN'T HAD ANY PREVIOUS COVID-19 VACCINES BEFORE HER NOVAVAX VACCINE" on 28-Oct-2023 after receiving COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) on 28-Oct-2023. At the time of the report, the outcome of the Somnolence was Unknown and Incomplete course of vaccination was Recovered/Resolved. On 25-May-2025, significant information was received from a consumer via query response - on an unknown date the patient "had very little side effects in the aftermath of my first dose" after receiving COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) on 28-Oct-2023. At the time of the report, the outcome of the Adverse event was Unknown.; Sender's Comments: This 23-year-old Female experienced Somnolence, Incomplete course of vaccination, and Adverse event after vaccination with COVID-19 Vaccine, Adjuvanted (2023-2024 Formula). The events Somnolence, Incomplete course of vaccination, and Adverse event were reported as non-serious. Based on the spontaneous nature of the report, the causal relationship between COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) and Incomplete course of vaccination, Somnolence, and Adverse event is considered Possible.
Medical History/Concurrent Conditions: SARS-CoV-2 test positive